News

Oral contraception and medical liability

Posted on: 11/12/2015 - 21:53

Question: Oral contraceptives are prescription drugs sold with highly specific manufacturer instructions on how and when to take them, because the sequence of pill ingestion is critical to...

Field of Interest: Pulmonology
Type: News Item

Hormone treatment associated with better kidney function

Posted on: 11/12/2015 - 21:17

SAN DIEGO – The use of hormone therapy was associated with a lower urine albumin-to-creatinine ratio and a decreased risk of albuminuria, results from a cross-sectional study suggest. “This may be...

Field of Interest: Pulmonology
Type: News Item

EADV: Focus on non-UV triggers of melanoma

Posted on: 11/12/2015 - 16:12

COPENHAGEN – Sunlight is recognized as the 800-pound gorilla of melanoma risk, with roughly 65% of all melanomas worldwide attributable to exposure to UV radiation. But what about the other...

Field of Interest: Oncology
Type: News Item

EADV: Focus on non-UV triggers of melanoma

Posted on: 11/12/2015 - 16:12

COPENHAGEN – Sunlight is recognized as the 800-pound gorilla of melanoma risk, with roughly 65% of all melanomas worldwide attributable to exposure to UV radiation. But what about the other...

Field of Interest: Dermatology
Type: News Item

EADV: Fresh insights into Gorlin syndrome

Posted on: 11/12/2015 - 14:40

COPENHAGEN – A glimpse into the massive burden imposed upon patients with basal cell nevus syndrome (BCNS) is provided by the initial report from the first U.S. registry of patients affected with the...

Field of Interest: Dermatology
Type: News Item

FDA sheds light on flibanserin approval

Posted on: 10/12/2015 - 18:52

The Food and Drug Administration is providing a rare look into the agency’s decision-making process surrounding the approval of flibanserin (Addyi) for female hypoactive sexual desire disorder (HSDD)...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More